Congressman Quayle Talks With Wolters Kluwer nv About Importance of Health Information
Published: Aug 25, 2011
As chairman of the Science, Space and Technology Committee’s Subcommittee on Technology and Innovation, Rep. Quayle wants to gain more insight into the health information business and talked with Pharma Solutions as one of the industry leaders that also happens to be based in his constituancy. The Congressman met with Pharma Solutions joint presidents Bob Jansen and Michelle Woker and others from the Phoenix-based healthcare analytics team including Cathy Betz,Vice President, Government Affairs, and the company’s Arizona lobbyists, TriAdvocates, where he received a presentation on health information technology.
“One of the things we shared with Congressman Quayle is our conviction that preserving good access to health information is vitally important to America’s health as a country,” said Bob Jansen, president of Wolters Kluwer Pharma Solutions’ healthcare analytics business. “The Congressman also shares the conviction that transparent and actionable health information is in the best interest of public health.”
The meeting also addressed the U.S. Supreme Court’s ruling in June that individual states may not prohibit the use of information about physician healthcare practices in the marketing of medicines. The court’s decision holds that a Vermont statute violates the First Amendment by banning the voluntary exchange of information on a matter of public importance. During the meeting, Rep. Quayle also discussed Pharma Solutions’ role as a major Phoenix employer, and the importance of companies like Pharma Solutions that bring jobs to the local economy. “Your business provides the economic diversification that we need to grow in Arizona so we are not beholden to the boom and bust of the real estate market,” the Congressman commented. Ben Quayle is a first term Congressman from Arizona and the son of former vice president Dan Quayle.
For more information, visit the company’s website at www.wolterskluwerpharma.com.
About Wolters Kluwer Pharma Solutions
Wolters Kluwer Pharma Solutions, Inc. (Phoenix, AZ and Yardley, PA) is a leading provider of information and analytics to the pharmaceutical, biotech, and medical device industries. The company’s brands include Adis, Source® and Lippincott Williams & Wilkins. A provider of business intelligence and services, Adis publishes 19 peer-reviewed drug research journals and 2 newsletters and offers the most respected drug and clinical trials databases in the pharma industry. Lippincott Williams & Wilkins (LWW) is a leading international healthcare publisher with nearly 300 periodicals and 1,500 books in more than 100 disciplines. A longstanding provider of market data and healthcare analytics, Source® offers a unique set of comprehensive patient and physician-level prescribing and usage data. For more information, visit www.wolterskluwerpharma.com.
The company is a wholly owned subsidiary of Wolters Kluwer, U.S., part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer’s leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer has 2010 annual revenues of €3.6 billion ($4.7 billion), employs approximately 18,200 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.
Thomas M. Kivett
Kivett & Company Communications, LLC
303 West 19th Street, 6th Fl.
New York, NY 10011
phone: (212) 727-2935
fax: (212) 727-2552